luvometinib
N-[3-[6-cyclopropyl-3-fluoro-4-(2-fluoro-4-iodoanilino)-1-methyl-2,5-dioxopyrido[2,3-d]pyridazin-8-yl]phenyl]cyclopropanesulfonamide
Molecular Identity
luvometinib
N-[3-[6-cyclopropyl-3-fluoro-4-(2-fluoro-4-iodoanilino)-1-methyl-2,5-dioxopyrido[2,3-d]pyridazin-8-yl]phenyl]cyclopropanesulfonamide
PubChem CID: 135210935
2D Structure
Properties
C26H22F2IN5O4S
Molecular Formula
665.50
Molecular Weight
g/mol
665.0405
Exact Mass
Da
4.2
XLogP
Drug-like (Lipinski: < 5)
120
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
9
H-Bond Acceptors
1270
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(16)
luvometinibFCN159FCN-1592739690-43-6B2DYT4V89XRefChem:1088629luvometinib [INN]orb2695285CHEMBL6068059SCHEMBL20366250GTPL13495EX-A12779Example 6 [WO2014169843]N-(3-(6-Cyclopropyl-3-fluoro-4-((2-fluoro-4-iodophenyl)amino)-1-methyl-2,5-dioxo-1,2,5,6-tetrahydropyrido[2,3-d]pyridazin-8-yl)phenyl)cyclopropanesulfonamideN-[3-[6-cyclopropyl-3-fluoro-4-(2-fluoro-4-iodoanilino)-1-methyl-2,5-dioxopyrido[2,3-d]pyridazin-8-yl]phenyl]cyclopropanesulfonamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to luvometinib
Loading drug network...